9.08
Phreesia Inc stock is traded at $9.08, with a volume of 1.71M.
It is up +3.53% in the last 24 hours and down -0.98% over the past month.
Phreesia Inc is a provides an integrated software, payments, and engagement platform designed to address three foundational challenges in healthcare delivery: access to care, affordability of care, and patient health outcomes. Its platform is embedded directly into provider workflows and patient interactions, enabling healthcare organizations to activate patients, streamline administrative processes, and improve financial performance across the care continuum. The group serves a diverse group of healthcare organizations, including ambulatory practices, health systems, and hospitals, as well as life sciences companies, government entities, patient advocacy, public interest, and not-for-profit and other organizations.
See More
Previous Close:
$8.77
Open:
$8.85
24h Volume:
1.71M
Relative Volume:
0.87
Market Cap:
$560.91M
Revenue:
$480.59M
Net Income/Loss:
$2.31M
P/E Ratio:
261.67
EPS:
0.0347
Net Cash Flow:
$51.23M
1W Performance:
-5.12%
1M Performance:
-0.98%
6M Performance:
-53.67%
1Y Performance:
-64.25%
Phreesia Inc Stock (PHR) Company Profile
Name
Phreesia Inc
Sector
Industry
Phone
888-654-7473
Address
1521 CONCORD PIKE, WILMINGTON
Compare PHR vs VEEV, BTSG, TEM, HQY, HNGE
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
PHR
Phreesia Inc
|
9.08 | 541.76M | 480.59M | 2.31M | 51.23M | 0.0347 |
|
VEEV
Veeva Systems Inc
|
163.85 | 25.93B | 3.20B | 908.91M | 1.39B | 5.4168 |
|
BTSG
Brightspring Health Services Inc
|
56.18 | 11.23B | 13.65B | 169.86M | 412.12M | 1.0758 |
|
TEM
Tempus Ai Inc
|
43.62 | 7.89B | 1.36B | -302.91M | -219.93M | -1.7182 |
|
HQY
Healthequity Inc
|
83.04 | 6.89B | 1.31B | 215.20M | 408.32M | 2.4627 |
|
HNGE
Hinge Health Inc
|
54.71 | 4.22B | 587.86M | -425.10M | 0 | -5.691 |
Phreesia Inc Stock (PHR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-01-26 | Downgrade | Citizens | Mkt Outperform → Mkt Perform |
| Mar-31-26 | Downgrade | Citigroup | Buy → Neutral |
| Mar-31-26 | Downgrade | JP Morgan | Overweight → Neutral |
| Mar-31-26 | Reiterated | Needham | Buy |
| Mar-31-26 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Mar-31-26 | Downgrade | Truist | Buy → Hold |
| Jan-09-26 | Resumed | RBC Capital Mkts | Outperform |
| Jan-09-26 | Initiated | Wells Fargo | Overweight |
| Dec-09-25 | Initiated | Barclays | Overweight |
| Nov-13-25 | Initiated | BMO Capital Markets | Outperform |
| Sep-05-25 | Resumed | DA Davidson | Buy |
| Aug-27-25 | Initiated | Mizuho | Outperform |
| Jan-08-25 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Feb-26-24 | Initiated | Truist | Buy |
| Jan-17-24 | Upgrade | DA Davidson | Neutral → Buy |
| Jan-03-24 | Initiated | Barclays | Overweight |
| Apr-12-23 | Initiated | Stephens | Overweight |
| Jan-04-23 | Reiterated | Needham | Buy |
| Dec-13-22 | Upgrade | Citigroup | Neutral → Buy |
| Dec-09-22 | Upgrade | SVB Leerink | Mkt Perform → Outperform |
| Oct-13-22 | Initiated | DA Davidson | Neutral |
| Sep-16-22 | Initiated | KeyBanc Capital Markets | Overweight |
| Apr-14-22 | Initiated | Guggenheim | Buy |
| Jan-06-22 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Dec-02-21 | Initiated | Jefferies | Buy |
| Sep-02-21 | Reiterated | Needham | Buy |
| Aug-27-21 | Initiated | Canaccord Genuity | Buy |
| Jul-13-21 | Initiated | JMP Securities | Mkt Outperform |
| Jun-08-21 | Initiated | Berenberg | Buy |
| Apr-29-21 | Resumed | JP Morgan | Overweight |
| Apr-01-21 | Initiated | Robert W. Baird | Outperform |
| Nov-11-20 | Initiated | Stephens | Overweight |
| Oct-27-20 | Initiated | Needham | Buy |
| Sep-22-20 | Initiated | DA Davidson | Buy |
| Jul-14-20 | Initiated | Citigroup | Neutral |
| May-15-20 | Initiated | Guggenheim | Buy |
| Apr-21-20 | Initiated | RBC Capital Mkts | Sector Perform |
| Apr-13-20 | Initiated | SVB Leerink | Outperform |
| Jan-31-20 | Initiated | KeyBanc Capital Markets | Overweight |
| Jan-09-20 | Initiated | Cantor Fitzgerald | Overweight |
| Dec-20-19 | Initiated | Raymond James | Outperform |
| Oct-11-19 | Initiated | Robert W. Baird | Outperform |
| Aug-13-19 | Initiated | JP Morgan | Overweight |
| Aug-12-19 | Initiated | Piper Jaffray | Overweight |
| Aug-12-19 | Initiated | Wells Fargo | Outperform |
| Aug-12-19 | Initiated | William Blair | Outperform |
| Jul-23-19 | Initiated | Chardan Capital Markets | Buy |
View All
Phreesia Inc Stock (PHR) Latest News
PHR Class Action Notice: Robbins LLP Reminds Investors of - GlobeNewswire
PHR Class Action Notice: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the Phreesia, Inc. Class Action Lawsuit - GlobeNewswire Inc.
PHR Shareholder Alert: Phreesia, Inc. Securities Class - GlobeNewswire
PHR (PHR) restricted stock vests; Yvonne Hui sold 11,390 shares - Stock Titan
PHR CLASS ACTION ALERT: Johnson Fistel Encourages Phreesia, - GlobeNewswire
Bronstein, Gewirtz & Grossman LLC Urges Phreesia, Inc. Investors to Act: Class Action Filed Alleging Investor Harm - Carroll County Mirror-Democrat
These analysts slash their forecasts on Phreesia following Q4 results - MSN
Phreesia (NYSE:PHR) Stock Rating Lowered by Barclays - MarketBeat
INVESTOR ALERT: Securities Class Action Filed Against Phreesia, Inc. – Investors Encouraged to Conta - PharmiWeb.com
INVESTOR ALERT: Securities Class Action Filed Against Phreesia, Inc. – Investors Encouraged to Contact Kirby McInerney LLP - lincolnjournal.com
Phreesia (PHR) Faces Federal Securities Lawsuit Over Alleged Misleading Revenue Guidance - TipRanks
PHR Investors Have Opportunity to Lead Phreesia, Inc. Securities Fraud Lawsuit with the Schall Law Firm - GlobeNewswire
PHREESIA CLASS ACTION ALERT: Bragar Eagel & Squire, P.C. - GlobeNewswire
PHR Downgraded by Barclays -- Price Target Lowered to $10.00 - GuruFocus
Phreesia Cut to Equal-Weight From Overweight by Barclays - Moomoo
PHR Shareholder Alert: Phreesia, Inc. Securities Class Action LawsuitInvestors Should Contact The Gross Law Firm - GlobeNewswire
Barclays Downgrades Phreesia to Equalweight From Overweight, Adjusts Price Target to $10 From $24 - marketscreener.com
PHR Stockholder Alert: Shareholder Rights Law Firm Robbins LLP R - GuruFocus
Barclays downgrades Phreesia (PHR) - MSN
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Phreesia, Inc. of Class Action Lawsuit and Upcoming DeadlinesPHR - PR Newswire
Phreesia faces class action over lowered 2027 revenue outlook and weakened pharma marketing commitments. - Pluang
Phreesia (PHR) Downgraded by Barclays Amid Slowing Digital Growt - GuruFocus
PHR Stockholder Alert: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Securities Class Action Lawsuit Against Phreesia, Inc. - PR Newswire
Phreesia, Inc. ($PHR) CEO 2026 Pay Revealed - Quiver Quantitative
Rosen Law Firm Urges Phreesia, Inc. (NYSE: PHR) Stockholders to Contact the Firm for Information About Their Rights - PharmiWeb.com
Phreesia (PHR) 2026 proxy details board refresh, virtual meeting and say-on-pay - Stock Titan
PHR Investors Have Opportunity to Lead Phreesia, Inc. Securities Fraud Lawsuit - Barchart.com
PHR INVESTOR NOTICE: Faruqi & Faruqi, LLP Notifies Phreesia (PHR) Investors of Securities Class Action Deadline on July 13, 2026 - PR Newswire
Press releases provided by CNW - Techaeris
PHR DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Phreesia (PHR) I - The National Law Review
Investor Notice: Robbins LLP Informs Investors of the Phreesia, Inc. Class Action - Business Wire
Phreesia investors urged to act before July 13 deadline in securities class action over revenue issues. - Pluang
PHR DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Phreesia - GlobeNewswire
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors - GlobeNewswire
Phreesia Sets May 27 Date for Quarterly Results - MyChesCo
Law firm investigates Phreesia for possible securities fraud after revenue guidance cut and stock plunge. - Pluang
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Phreesia, Inc.PHR - ChartMill
Phreesia Inc. buy DomRuinart - sharewise.com
Phreesia Announces Workforce Restructuring to Cut Operating Costs - TipRanks
Job cuts at Phreesia (NYSE: PHR) as restructuring targets 220 roles - Stock Titan
Phreesia Reports New $275 Million Revolving Credit Facility - Moomoo
Phreesia (PHR) Slid on Guidance Cut - Insider Monkey
Phreesia, Inc. (PHR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Health Check: How Prudently Does Phreesia (NYSE:PHR) Use Debt? - 富途牛牛
Phreesia, Inc. Enters Material Definitive Agreement with PNC Bank and AccessOne Holdings – 2026 8-K Filing Details - Minichart
Bronstein, Gewirtz & Grossman, LLC Encourages Phreesia, Inc. (PHR) Shareholders to Inquire about Securities Investigation - ACCESS Newswire
Phreesia Expands Receivables Facility and Guarantees Obligations - TipRanks
Phreesia (NYSE: PHR) director takes stock units instead of cash retainer - Stock Titan
Phreesia (PHR) director opts for 1,085 deferred stock units as fees - Stock Titan
Gillian Munson (NYSE: PHR) takes fees in 1,085 stock units - Stock Titan
Phreesia IncIncreases receivables purchase facility limit to $300 million from $200 millionSEC filing - marketscreener.com
Phreesia Inc Stock (PHR) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):